{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-21-017730","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.491570+00:00","generated_at":"2026-06-28T08:55:24.100184+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Charles River Laboratories promotes Birgit Girshick to COO, adds Research Models & Services oversight","bullets":["Birgit Girshick promoted to Executive VP and COO, effective November 11, 2021.","She adds Research Models and Services to her existing responsibilities for Discovery, Safety Assessment, Biologics Solutions, and Cell & Gene Therapy CDMO.","Girshick has been with Charles River since 1989, leading strategic initiatives and integrating acquisitions like Cognate BioServices and Vigene Biosciences.","James C. Foster remains Chairman, President and CEO; his employment agreement was extended to February 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-21-017730","json":"https://secwatch.observer/filing/0000950103-21-017730.json","markdown":"https://secwatch.observer/filing/0000950103-21-017730.md","text":"https://secwatch.observer/filing/0000950103-21-017730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/0000950103-21-017730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/dp161684_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T08:55:24.100184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d53cca259","claim":"Birgit Girshick was appointed as Chief Operating Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"On November 11, 2021, Charles River Laboratories International, Inc. (the \"Company\") announced that Ms. Birgit Girshick, Corporate Executive Vice President, Discovery and Safety Assessment and Biologics Testing Solutions, will become Chief Operating Officer of the Company, effective immediately, and will add Research Models and Services to her responsibilities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/0000950103-21-017730-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}